|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|
| Current assets: | |||||
| Cash | |||||
| Prepaid expenses | |||||
| Due from related party | |||||
| Deferred offering costs | |||||
| Total Current Assets | |||||
| Cash and marketable securities held in Trust Account | |||||
| TOTAL Current Asset | |||||
| Current liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Accrued offering costs | |||||
| Due to related party | |||||
| Promissory note – related party | |||||
| Total Current Liabilities | |||||
| Deferred underwriting commission | |||||
| Class A ordinary shares subject to possible redemption, 8,625,000 shares at redemption value of $10.38 and $10.28 per share at March 31, 2025 and December 31, 2024, respectively | |||||
| Shareholders’ Deficit | |||||
| Ordinary shares value | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ Deficit | |||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
Loading...
